Glaukos (GKOS) Cash & Current Investments (2014 - 2026)
Glaukos' (GKOS) quarterly Cash & Current Investments came in at $104.2 million in Q1 2026, down 8.76% year-on-year from $114.3 million in Q1 2025, and up 14.8% on a QoQ basis from $90.8 million in Q4 2025.
Glaukos (GKOS) Cash & Current Investments (2014 - 2026) Analysis & Trends
Glaukos (GKOS) has 13 years of Cash & Current Investments data on file, last reported at $104.2 million in Q1 2026.
- On a quarterly basis, Cash & Current Investments fell 8.76% year-over-year to $104.2 million in Q1 2026; TTM through Mar 2026 was $104.2 million, a 8.76% decrease from a year earlier, with the FY2025 full-year figure at $90.8 million, down 46.46% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $104.2 million, up from $90.8 million in the prior quarter.
- Over the last five years, Cash & Current Investments for GKOS reached as high as $169.6 million in Q4 2024 and fell as low as $42.5 million in Q1 2024.
- Historically, Cash & Current Investments has averaged $99.7 million across 5 years, with a median of $100.8 million in 2025.
- On a YoY basis, Cash & Current Investments climbed as much as 168.86% in 2025 and fell as far as 46.46% in 2025.
- Year by year, Cash & Current Investments stood at $119.5 million in 2022, then retreated by 21.8% to $93.5 million in 2023, then jumped by 81.48% to $169.6 million in 2024, then sank by 46.46% to $90.8 million in 2025, then increased by 14.8% to $104.2 million in 2026.
- Per Business Quant data, the three most recent Cash & Current Investments figures were $104.2 million in Q1 2026, $90.8 million in Q4 2025, and $98.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 3.67 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 1.12 Bn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 2.29 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 577.00 Mn |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 3.12 Bn |
| 10 | Glaukos | 8.79 Bn | 8.68 Bn | 117.23 Mn | 104.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 104.25 Mn |
| Dec 31, 2025 | 90.81 Mn |
| Sep 30, 2025 | 98.25 Mn |
| Jun 30, 2025 | 100.81 Mn |
| Mar 31, 2025 | 114.25 Mn |
| Dec 31, 2024 | 169.63 Mn |
| Sep 30, 2024 | 100.14 Mn |
| Jun 30, 2024 | 68.08 Mn |
| Mar 31, 2024 | 42.50 Mn |
| Dec 31, 2023 | 93.47 Mn |
| Sep 30, 2023 | 108.93 Mn |
| Jun 30, 2023 | 94.81 Mn |
| Mar 31, 2023 | 76.40 Mn |
| Dec 31, 2022 | 119.53 Mn |
| Sep 30, 2022 | 104.02 Mn |
| Jun 30, 2022 | 102.55 Mn |
| Mar 31, 2022 | 106.20 Mn |
| Dec 31, 2021 | 100.71 Mn |
| Sep 30, 2021 | 113.13 Mn |
| Jun 30, 2021 | 118.30 Mn |